Condition

Chemotherapy Induced Thrombocytopenia clinical trials and research

• 8Clinical trials
• 5Countries

Newest Chemotherapy Induced Thrombocytopenia clinical trials

All recruiting trials (8)

• Romiplostim N01 plus ATRA for persistent chemotherapy-induced low platelets after remission from gynecologic, breast, or lung cancer

  This trial tests whether adding ATRA to Romiplostim N01 helps people keep a safe platelet count after finishing chemotherapy for certain cancers.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07586826

• Romiplostim N01 plus ATRA for persistent low platelets after cancer remission

  This study tests whether adding all-trans retinoic acid to Romiplostim N01 helps people who still have low platelets after GI/digestive system cancer remission reach safer platelet levels.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07586813

• Romiplostim N01 to treat chemotherapy-related low platelets

  This will test whether Romiplostim N01 can raise platelet counts in adults whose platelets remain very low after chemotherapy and did not respond to other platelet-boosting drugs.

  Recruiting Phase 2 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07063225

• Romiplostim to prevent chemotherapy-related low platelets in Ewing sarcoma

  This trial will test whether giving romiplostim during interval-compressed chemotherapy can reduce episodes of low platelets in people with newly diagnosed Ewing sarcoma.

  Recruiting at 2 sites Early Phase 1 Children's Hospital Medical Center, Cincinnati · Phoenix, Arizona and 1 other locations · NCT07048249

• Romiplostim N01 for chemotherapy-related low platelets in children and young adults

  Romiplostim N01 will be tried to raise platelet counts in children and young adults (ages 6–24) who develop low platelets after chemotherapy for solid tumors or blood cancers.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing · NCT07043894

• Home monitoring of blood tests for cancer patients

  This study is testing if cancer patients can do their blood tests at home during chemotherapy to make things easier and improve their care.

  Recruiting at 5 sites Pomeranian Medical University Szczecin · Næstved, Region Sjælland and 4 other locations · NCT06809101

• Using Herombopag to treat low platelet counts from chemotherapy

  This study is testing if a new medication called Herombopag can help increase low platelet counts in patients who have not responded well to other treatments after chemotherapy.

  Recruiting Phase 2 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT05236582

• Eltrombopag treatment for low platelet counts caused by chemotherapy

  This study is testing if eltrombopag can help increase low platelet counts in patients who haven't responded to other treatments after chemotherapy.

  Recruiting Phase 2 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT04600960

Related topics

Quick answers

How many Chemotherapy Induced Thrombocytopenia clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in China (6 trials), United States (1 trial), Denmark (1 trial), Germany (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →